Maravai LifeSciences Inc...

NASDAQ: MRVI · Real-Time Price · USD
2.62
0.02 (0.77%)
At close: Aug 15, 2025, 3:59 PM
2.62
0.19%
After-hours: Aug 15, 2025, 06:49 PM EDT

Maravai LifeSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-224.97M -162.71M -144.85M -224.66M -132.08M -136.44M -125.71M 67.68M 173.79M 342.45M 490.66M 529.48M 562.63M 540.26M 469.25M 357.48M 263.69M 130.79M
Depreciation & Amortization
57.39M 58.78M 57.62M 56.07M 54.38M 51.63M 48.78M 45.83M 42.64M 41.63M 38.1M 31.52M 28.68M 25.24M 24.75M 27.23M 26.83M 25.96M
Stock-Based Compensation
40.79M 47.76M 49.41M 48.21M 45.15M 40.66M 34.59M 31.24M 25.99M 21.03M 18.67M 14.9M 13.73M 11.81M 10.46M 29.92M 28.21M 26.4M
Other Working Capital
-5.52M -6.58M -27.83M -14.89M -10.16M -7.7M 7.52M -9.96M -23.89M -31.97M -30.69M -81.5M -113.68M -124.4M -85.34M -9.79M 88.03M 109.53M
Other Non-Cash Items
101.69M 56.53M 55.22M -617.24M -698.29M -698.48M -684.22M -3.88M -1.91M -5.44M -8.7M -229K -11.17M -1.49M -6.16M -13.3M 1.91M 2.7M
Deferred Income Tax
11K 11K 11K 765.06M 759.22M 756.46M 754.94M -2.8M 11.97M 27.58M 42.32M 52.77M 54.77M 48.36M 46.9M 25.25M 14.02M 7.57M
Change in Working Capital
3.94M 6.18M -9.95M 2.44M 2.55M 18.86M 97.84M 79.7M 61.18M 31.5M -45.08M -133.64M -158.04M -132.01M -176.63M -36.75M 748K -12.23M
Operating Cash Flow
-21.16M 6.54M 7.46M 29.89M 30.92M 32.68M 126.22M 217.77M 313.66M 458.75M 535.98M 494.81M 490.61M 492.16M 368.57M 389.83M 335.41M 181.19M
Capital Expenditures
-23.05M -29.73M -30.16M -40.61M -47.84M -63.35M -65.55M -54.97M -45.61M -22.21M -17.09M -16.54M -11.48M -14.02M -14.85M -18.04M -26.72M -25.58M
Cash Acquisitions
-18.99M -18.63M n/a 74.91M 74.91M 75.02M 5.29M -69.75M -69.14M -69.24M -238.35M -238.22M -118.88M -118.88M 120.5M 117.48M -2.48M -2.48M
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
1.28M 4.66M 5.34M -66.59M -65.92M -68.49M -62.05M -3.2M -2.89M -3.68M -11.55M 620K 119.96M 119.96M 120.5M 123.53M 3.57M 3.57M
Investing Cash Flow
-40.26M -43.2M -24.32M -32.29M -38.85M -56.82M -122.31M -127.93M -118.25M -95.76M -267.61M -254.75M -130.36M -132.9M 105.66M 102.47M -26.17M -25.03M
Debt Repayment
-232.6M -234.11M -234.07M -6.04M -6M -5.92M -5.77M -5.63M -5.51M -5.44M -5.44M -5M -5.36M -5.72M -6M 178.74M 179.89M 180.94M
Common Stock Repurchased
-621K -649K -2.08M -1.48M -1.46M -1.43M -333K -333K -333K -333K n/a n/a n/a n/a n/a -42.8M -42.8M -42.8M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-2.62M 681K 1.68M 8.81M 8.73M -34.74M -54.63M -121.72M -160.07M -160.41M -182.06M -165.76M -179.24M -169.59M -152.99M -247.68M -198.48M -166.27M
Financial Cash Flow
-240.57M -238.81M -234.47M 947K 921K -42.44M -61.09M -127.68M -165.91M -166.19M -187.5M -170.37M -184.43M -175.37M -159.05M -69.38M -18.82M 14.67M
Net Cash Flow
-303.26M -276.64M -252.56M -1.45M -7M -66.58M -57.18M -37.84M 29.5M 196.8M 80.87M 69.55M 175.97M 183.79M 315.09M 423.02M 290.25M 170.93M
Free Cash Flow
-44.21M -23.19M -22.69M -10.71M -16.92M -30.67M 60.67M 162.8M 268.05M 436.54M 518.89M 478.27M 479.13M 478.14M 353.72M 371.8M 308.68M 155.61M